Genetic toxicology of a paradoxical human carcinogen, arsenic: A review

Mutation Research - Reviews in Mutation Research

Volumn 488, Issue 2, 2001, Pages 171-194

  Basu, A ^a   Mahata, J ^a   Gupta, S ^a   Giri, A K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Arsenic; DNA damage; Genotoxicity; Mutagenicity; Review

Indexed keywords

ARSENIC; ARSENIC DERIVATIVE; CARCINOGEN; DNA; DRINKING WATER; GROUND WATER;

AIR ANALYSIS; CARCINOGENESIS; CARCINOMA; CHROMOSOME ANALYSIS; DNA DAMAGE; GENETIC TOXICOLOGY; GENOTOXICITY; GLASS INDUSTRY; HEALTH STATUS; HUMAN; MUTAGENESIS; NONHUMAN; PAPER INDUSTRY; PRIORITY JOURNAL; REVIEW; SEMICONDUCTOR; SKIN CARCINOMA; SOIL; WATER ANALYSIS; WATER CONTAMINATION;

ANIMALS; ARSENIC; CARCINOGENS; CHROMOSOME ABERRATIONS; CYTOGENETICS; DNA DAMAGE; HUMANS; INDIA; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTAGENS; SISTER CHROMATID EXCHANGE; WATER POLLUTANTS, CHEMICAL;

ANIMALIA;

EID: 0035015116     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(01)00056-4     Document Type: Review

References (183)

1. Roychowdhury T., Basu G.K., Mandal B.K., Biswas B.K., Samanta G., Chowdhury U.K., Chanda C.R., Lodh D., Roy S.L., Saha K., Roy S., Kabir S., Quamruzzaman Q., Chakraborti D. Arsenic poisoning in the ganges delta, brief communications. Nature. 401:1999;545-546.
2. Das D., Chatterjee A., Mandal B.K., Samanta G., Chakraborty D. Arsenic in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. Analyst. 120:1995;917-924.
3. Jager J.W., Ostosky-Wegman P. Arsenic: a paradoxical human carcinogen. Mutat. Res. 386:1997;181-184.
4. Giri A.K. Genetic toxicology of vinyl chloride: a review. Mutat. Res. 339:1995;1-14.
5. Giri A.K., Banerjee S. Genetic toxicology of four commonly used benzodiazepines: a review. Mutat. Res. 340:1996;93-108.
6. Giri A.K. Genetic toxicology of epichlorohydrin: a review. Mutat. Res. 386:1997;25-38.
7. Chatterjee T., Mukhopadhyay A., Khan K.A., Giri A.K. Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine. Mutagenesis. 13:1998;619-624.
8. Giri A.K., Mukhopadhyay A. Mutagenicity assay in Salmonella and in vivo sister chromatid exchange in bone marrow cells of mice for four pyrazolone derivatives. Mutat. Res. 420:1998;15-25.
9. Giri A.K., Das M., Reddy V.G., Pal A.K. Mutagenic and genotoxic effects of theophylline and theobromine in Salmonella assay and in vivo sister chromatid exchanges in bone marrow cells of mice. Mutat. Res. 444:1999;17-23.
10. Hei T.K., Liu S.X., Waldren C. Mutagenicity of arsenic in mammalian cells; role of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8103-8107.
11. de la Rosa M.E., Magnusson J., Ramel C., Nilsson R. Modulating influence of inorganic arsenic on the recombinogenic and mutagenic action of ionizing radiation and alkylating agents in Drosophila melanogaster. Mutat. Res. 318:1994;65-71.
12. Lee T.C., Oshimura M., Barrett J.C. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis. 6:1985;1421-1426.
13. Mitchell N., Stohrer G. Mutagenesis originating in site specific DNA damage. J. Mol. Biol. 191:1986;177-180.
14. Li J.H., Rossman T.G. Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol. Met. 4:1991;197-200.
15. M.M. Moore, K. Harrington-Brock, C.L. Doerr, Genotoxicity of arsenic and its methylated metabolites, in: W.R. Chappel, C.R. Cothens (Eds.), Arsenic: Exposure and Health, Science and Technology Letters, Norwood, England, 1993, pp. 191-198.
16. Andersen K.J., Leighty E.G., Takahashi M.T. Evaluation of herbicides for possible mutagenic properties. J. Agric. Food Chem. 20:1972;649-656.
17. Shelby M.D. The genetic toxicity of human carcinogens and its implications. Mutat. Res. 204:1988;3-15.
18. Jongen W.M., Cardinaals J.M., Bos P.M., Hagel P. Genotoxicity testing of arsenobetaine, the predominant form of arsenic in marine fishery products. Fd. Chem. Toxicol. 23:1985;669-673.
19. Kharab P., Singh I. Genotoxic effects of potassium dichromate, sodium arsenite, cobalt chloride, and lead nitrate in diploid yeast. Mutat. Res. 155:1985;117-120.
20. G.M. Nii Lo Piccolo, M.A. Thesis, Western Michigan University, Kalamazoo, MI, 1972.
21. Nishioka H. Mutagenesis of metals in bacteria. II. As, Cr and Hg compounds and test tube method for detection of chemicals mutagenicity. Jpn. J. Genet. 49:1974;315.
22. Nishioka H. Mutagenic activities of metal compounds in bacteria. Mutat. Res. 31:1975;185-198.
23. Ficsor G., Nii Lo Piccolo G.M. Survey of pesticides for mutagenicity by the bacterial-plate assay method. EMS Newsl. 6:1972;6-8.
24. Neubauer O. Arsenical cancer: a review. Br. J. Cancer. 1:1946;192-196.
25. Rossman T.G., Stone D., Molina M., Troll W. Absence of arsenite mutagenicity in E. coli and Chinese hamster cells. Environ. Mutagen. 2:1980;371-379.
26. Rossman T.G. Enhancement of UV-mutagenesis by low concentrations of arsenite in E. coli. Mutat. Res. 91:1981;207-211.
27. Yamanaka K., Ohba H., Hasegawa A., Sawamura R., Okada S. Mutagenicity of dimethylated metabolites of inorganic arsenics. Chem. Pharm. Bull. 37:1989;2753-2756.
28. Okui T., Fujiwara Y. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat. Res. 172:1986;69-76.
29. T.G. Rossman, Arsenite genotoxicity may be mediated by interference with DNA damaging-inducible signaling, in: W.R. Chappell, C.O. Abernathy, R.L. Calderon (Eds.), Arsenic Exposure and Health Effects, Elsevier, New York, 1999, pp. 233-241.
30. Walker G.W.R., Bradley A.M. Interacting effects of sodium monohydrogenarsenate and selenocystine on crossing over in Drosophila melanogaster. Can. J. Genet. Cytol. 11:1969;677-688.
31. Ahmed Z.U., Walker G.W.R. Studies on the effect of urethane, selenocystine and sodium monohydrogenarsenate on crossing over in the X-chromosome of Drosophila melanogaster. Can. J. Genet. Cytol. 14:1972;719.
32. Rasmuson A. Mutagenic effects of some water-soluble metal compounds in a somatic eye-colour test system in Drosophila melanogaster. Mutat. Res. 157:1985;157-162.
33. Ramos-Morales P., Rodriguez-Arnaiz R. Genotoxicity of two arsenic compounds in germ cells and somatic cells of Drosophila melanogaster. Environ. Mol. Mutagen. 25:1995;288-299.
34. Tripathy N.K., Wurgler F.E., Frei H. Genetic toxicity of six carcinogens and six noncarcinogens in the Drosophila wing spot test. Mutat. Res. 242:1990;169-180.
35. Sram R.J., Beneko V. A contribution to the evaluation of the genetic risk of exposure to arsenic. Cesh. Hygiene. 19:1974;308-315.
36. Pashin Iu V., Kozachenko V.I., Toroptsev S.N. Arsenic trioxide inhibition of the thiophosphamide induction of mutations in mouse germ and somatic cells. Genetika. 20:1984;365-366.
37. Deknudt G., Leonard A., Arany J., Jenar-Du-Buission G., Delavignette E. In vivo studies in male mice on the mutagenic effects of inorganic arsenic. Mutagenesis. 1:1986;33-34.
38. Wiencke J.K., Yager J.W., Varkonyi A., Hultner M., Lutze L.H. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat. Res. 386:1997;335-344.
39. Harrington-Brock K., Cabrera M., Collard D.D., Doerr C.L., Mc Connell R., Moore M.M., Sandoval H., Fuscoe J.C. Effects of arsenic exposure on the frequency of lymphocytes in a population of copper roasters in Antofagasta, Chile: a pilot study. Mutat. Res. 431:1999;247-257.
40. Nishioka H., Takagi K. Mechanism of mutation induction by metal compounds in bacteria. III. Metabolic activation. Jpn. J. Genet. 50:1975;485-486.
41. Shirasu Y., Moriya M., Kato K., Furuchashi A., Kada T. Mutagenicity screening of pesticides in the microbial system. Mutat. Res. 40:1976;19-30.
42. Rossman T.G., Meyn M.S., Troll W. Effects of arsenite on DNA repair in Escherichia coli. Environ. Health Perspect. 19:1977;229-233.
43. Okada S., Yamanaka K., Ohba H., Kawazoe Y. Effect of inorganic arsenics on cytotoxicity and mutagenicity of ultraviolet light on Escherichia coli and the mechanism involved. J. Pharmacobiodyn. 6:1983;496-504.
44. Yamanaka K., Hasegawa A., Sawamura R., Okada S. Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165:1989;43-50.
45. Yamanaka K., Hasegawa A., Sawamura R., Okada S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics in mice. Toxicol. Appl. Pharmacol. 108:1991;205-213.
46. Nakano M., Yamanaka K., Hasegawa A., Sawamura R., Okada S. Preferential increase of heterochromatin in venular endothelium of lung in mice after administration of dimethylarsinic acid, a major metabolite of inorganic arsenics. Carcinogenesis. 13:1992;391-393.
47. Yamanaka K., Tezuka M., Kato K., Hasegawa A., Okada S. Crosslink formation between DNA and nuclear proteins by in vivo and in vitro exposure of cells to dimethylarsinic acid. Biochem. Biophys. Res. Commun. 191:1993;1184-1191.
48. Yamanaka K., Okada S. Induction of lung specific DNA damage by methylated arsenics via the production of free radicals. Environ. Health Perspect. 102:1994;37-40.
49. Brown J.L., Kitchin K.T. Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase in rat liver: relevence to arsenic carcinogenesis. Cancer Lett. 98:1996;227-231.
50. Liu F., Jan K.Y. DNA damage in arsenite and cadmium-treated bovine aortic endothelial cells. Free Radic. Biol. Med. 28:2000;55-63.
51. Lee-Chen S.F., Yu C.T., Jan K.Y. Effects of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells. Mutagenesis. 7:1992;51-55.
52. Lee-Chen S.F., Yu C.T., Wu D.R., Jan K.Y. Differential effects of luminol, nickel and arsenite on the rejoining of ultraviolet light and alkylation induced DNA breaks. Environ. Mol. Mutagen. 23:1994;116-120.
53. Li J.H., Rossman T.G. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 2:1989;1-9.
54. Gebel T., Birkenkamp P., Luthin S., Dunkelberg H. Arsenic (III), but not antimony (III), induces DNA-protein crosslinks. Anticancer Res. 18:1998;4253-4257.
55. Piperakis M., McLennan A.G. Enhanced reactivation of UV-irradiated adenovirus 2 in HeLa cells treated with non-mutagenic chemical agents. Mutat. Res. 142:1985;83-85.
56. Chang M.J.W. Toxic effects of arsenic compounds on cultured human fibroblasts, in vitro Toxicology. J. Mol. Cell. Toxicol. 1:1987;103-110.
57. Dong J.T., Luo X.M. Effects of arsenic on DNA damage and repair in human fetal lung fibroblasts. Mutat. Res. 315:1994;11-15.
58. Yamanaka K., Hoshino M., Okamoto M., Sawamura R., Hasegawa A., Okada S. Induction of DNA damage by dimethylarsine a metabolite of peroxyl radical. Biochem. Biophys. Res. Commun. 168:1990;58-64.
59. Yamanaka K., Hayashi H., Kato K., Hasegawa A., Okada S. Involvement of preferential formation of apurinic/apyrimidinic sites in dimethylarsenic induced DNA strand breaks and DNA protein crosslinks in cultured alveolar epithelial cells. Biophys. Res. Commun. 207:1995;244-249.
60. Yamanaka K., Hayashi H., Tachikawa M., Kato K., Hasegawa A., Oku N., Okada S. Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat. Res. 394:1997;95-101.
61. Tezuka M., Hanioka K.I., Yamanaka K., Okada S. Gene damage induced in human alveolar type II (L-32) cells by exposure to dimethylarsinic acid. Biochem. Biophys. Res. Commun. 191:1993;1178-1183.
62. Kato K., Hayashi H., Hasegawa A., Yamanaka K., Okada S. DNA damage induced in cultured human alveolar (L-132) cells by exposure to dimethyl arsinic acid. Environ. Health Perspect. 102:1994;285-288.
63. Hartmann A., Speit G. Effect of arsenic and cadmium on the persistense of mutagen-induced DNA lesions in human cells. Environ. Mol. Mutagen. 27:1996;98-104.
64. Hartwig A., Groblinghoff U.D., Beyersmann D., Natarajan A.T., Filon R., Mullenders L.H. Interaction of arsenic (III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis. 18:1997;399-405.
65. Ramirez P., Del Razo L.M., Gutierrez-Ruiz M.C., Gonsebatt M.E. Arsenite induces DNA-protein crosslinks and cytokeratin expression in the WRL-68 human hepatic cell line. Carcinogenesis. 21:2000;701-706.
66. Hartmann A., Speit G. Comparative investigations of the genotoxic effects of metals in the single cells gel (SCG) assay and the sister chromatid exchange (SCE) test. Environ. Mol. Mutagen. 23:1994;299-305.
67. Schaumloffel N., Gebel T. Heterogeneity of the DNA damage provoked by antimony and arsenic. Mutagenesis. 13:1998;281-286.
68. Hu Y., Su L., Snow E.T. Arsenic toxicity is enzyme specific and its effect on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutat. Res. 408:1998;203-218.
69. Lynn S., Gurr J.R., Lai H.T., Jan K.Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86:2000;514-519.
70. Flessel C.P. Metals as mutagens. Adv. Exp. Med. Biol. 91:1977;117-128.
71. El-Sadek L.M. Mitotic inhibition and chromosomal aberrations induced by some arylarsonic acids and its compounds in root tips of maize. Egypt. J. Genet. Cytol. 1:1972;218-224.
72. Nygren A. Cytological studies of the effects of 2,4-D, MCPA and 2,4,5-T on Allium cepa. Ann. Roy. Agr. Coll. 16:1949;723-728.
73. Gill B.S., Sandhu S.S. Application of Tradescantia micronucleus assay for the genetic evaluation of chemical mixtures in soil and aqueous media. Mutat. Res. 270:1992;65-69.
74. Arroyo-Gomez S., Armienta M.A., Cortes-Eslava J., Villalobos-Pietrini R. Sister chromatid exchange in Vicia faba induced by arsenic contaminated drinking water from Zimapan, Hidalgo, Mexico. Mutat. Res. 394:1997;1-7.
75. Muller W.U., Streffer C., Fischer-Lahdo C. Toxicity of arsenite in mouse embroys in vitro and its influence on radiation risk. Arch. Toxicol. 59:1986;172-175.
76. IARC (International agency for research on cancer), IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Metals and Metallic Compounds, Vol. 23, Lyon, France, 1980.
77. Tinwell H., Stephens S.C., Ashby J. Arsenite as the probable active species in the carcinogenicity of arsenic: mouse micronucleus assay on Na and K arsenite, orpiment, and Fowlers solution. Environ. Health Perspect. 95:1991;205-210.
78. Tice R.R., Yager J.W., Andrews P., Crecelius E. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat. Res. 386:1997;315-334.
79. Poma K., Kirsch-Volders M., Susanne C., Degraeve N. Lack of synergistic effect between arsenic, mercury and ethylmethane sulphonate on the frequency of chromosomal aberrations in mice. J. Appl. Toxicol. 4:1984;293-296.
80. Moore M.M., Harrington-Brock K., Doerr C.L. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386:1997;279-290.
81. Nagymajtenyi L., Selypes A., Berencsi G. Chromosomal aberrations and fetotoxic effects of atmospheric arsenic exposure in mice. J. Appl. Toxicol. 5:1985;61-63.
82. Kashiwada E., Kuroda K., Endo G. Aneuploidy induced by dimethylarsinic acid in mouse bone marrow cells. Mutat. Res. 413:1998;33-38.
83. Das T., Roychoudhury A., Sharma A., Talukder G. Modification of clastogenicity of three known clastogens by garlic extract in mice in vivo. Environ. Mol. Mutagen. 21:1993;383-388.
84. Roychoudhury A., Das T., Sharma A., Talukder G. Dietary garlic extract in modifying clastogenic effects of inorganic arsenic in mice: two-generation studies. Mutat. Res. 359:1996;165-170.
85. Roychoudhury A., Das T., Sharma A. Mustard oil and garlic extract as inhibitors of sodium arsenite-induced chromosomal breaks in vivo. Cancer Lett. 121:1997;45-52.
86. Roychoudhury A., Das T., Sharma A., Talukder G. Inhibition of clastogenic effects of arsenic through continuted oral administration of garlic extract in mice in vivo. Mutat. Res. 392:1997a;237-242.
87. Biswas S., Talukder G., Sharma A. Protection against cytotoxic effects of arsenic by dietary supplimentation with crude extract of Emblica officinalis fruit. Phytother. Res. 13:1999;513-516.
88. Biswas S., Talukder G., Sharma A. Prevention of cytotoxic effects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mutat. Res. 441:1999a;155-160.
89. Poddar S., Mukherjee P., Talukder G., Sharma A. Dietary protection by iron against clastogenic effects of short-term exposure to arsenic in mice in vivo. Fd. Chem. Toxicol. 38:2000;735-737.
90. Gebel T., Kevekordes S., Schaefer J., von Platen H., Dunkelberg H. Assessment of a possible genotoxic environmental risk in sheep bred on grounds with strongly elevated contents of mercury, arsenic and antimony. Mutat. Res. 368:1996;267-274.
91. Wan B., Christian R.T., Soukup S.W. Studies of cytogenetic effects of sodium arsenicals on mammalian cells in vitro. Environ. Mutagen. 4:1982;493-498.
92. Lee T.C., Huang R.Y., Jan K.Y. Sodium arsenite enhances the cytotoxicity, clastogenicity and 6-thioguanine resistant mutagenicity of ultraviolet light in chinese hamster ovary cells. Mutat. Res. 148:1985;83-89.
93. Lee T.C., Tzeng S.F., Chang W.J., Lin Y.C., Jan K.Y. Post-treatments with sodium arsenite during G2 enhance the frequency of chromosomal aberrations induced by S-dependent clastogens. Mutat. Res. 163:1986;263-269.
94. Lee T.C., Wang-Wuu S., Huang R.Y., Lee K.C., Jan K.Y. Differential effects of pre- and post-treatment of sodium arsenite on the genotoxicity of methylmethane sulphonate in Chinese hamster ovary cells. Cancer Res. 46:1986;1854-1857.
95. Lee T.C., Lee K.C., Tzeng Y.J., Huang R.Y., Jan K.Y. Sodium arsenite potentiates the clastogenicity and mutagenicity of DNA crosslinking agents. Environ. Mutagen. 8:1986;119-128.
96. Jan K.Y., Huang R.Y., Lee T.C. Different modes of action of sodium arsenite, 3-aminobenzamide, and caffeine on the enhancement of ethyl methanesulphonate clastogenicity. Cytogenet. Cell. Genet. 41:1986;202-208.
97. K.Y. Jan, J.L. Yang, Y.J. Tzeng, R.Y. Huang, T.C. Lee, Sodium arsenite mediated synergistical increase in chromosome aberrations induced by alkylating agents in mammalian cells, in: H.K. Dillon, M.H. Ho (Eds.), Biological Monitoring of Exposure to Chemicals: Metals, Wiley, New York, 1991, pp. 111-118.
98. Lin J.K., Tseng S.F. Chromosomal aberrations and sister-chromatid exchanges induced by N-nitroso-2-acetylaminofluorene and their modifications by arsenite and selenite in Chinese hamster ovary cells. Mutat. Res. 265:1992;203-210.
99. Lee T.C., Kao S.L., Yih L.H. Suppression of sodium arsenite-potentiated cytotoxicity of ultra-violet light by cycloheximide in Chinese hamster ovary cells. Arch. Toxicol. 65:1991;640-645.
100. Huang R.Y., Lee T.C., Jan K.Y. Cycloheximide suppresses the enhancing effect of sodium arsenite on the clastogenicity of ethylmethanesulphonate. Mutagenesis. 6:1986;467-470.
101. Huang R.Y., Jan K.Y., Lee T.C. Posttreatment with sodium arsenite is coclastogenic in log phase but not in stationary phase. Hum. Genet. 2:1987;159-162.
102. Huang H., Huang C.F., Huang J.S., Wang T.C., Jan K.Y. The transition from late G1 to early S phase is most vulnerable to the coclastogenic effect of ultraviolet radiation plus arsenite. Int. J. Radiat. Biol. 61:1992;57-62.
103. Huang H., Huang C.F., Wu D.R., Jinn C.M., Jan K.Y. Glutathione as a cellular defence against arsenite toxicity in cultured Chinese hamster ovary cells. Toxicology. 79:1993;195-204.
104. Gurr J.R., Linn Y.C., Ho I.C., Jan K.Y., Lee T.C. Indution of chromatid breaks and tetraploidy in Chinese hamster ovary cells by treatment with sodium arsenite during the G2 phase. Mutat. Res. 319:1993;135-142.
105. Wang T.S., Huang H. Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. Mutagenesis. 9:1994;253-257.
106. Kochhar T.S., Howard W., Hoffman S., Brammer-Carleton L. Effect of trivalent and pentavalent arsenic in causing chromosome alterations in cultured Chinese hamster ovary cells. Toxicol. Lett. 84:1996;37-42.
107. Fan S.R., Ho I.C., Yeoh F.L.F., Lin C.J., Lee T.C. Squalene inhibites sodium arsenite induced sister chromatid exchanges and micronuclei in Chinese hamster ovary - K1 cells. Mutat. Res. 368:1996;165-169.
108. Liu Y.C., Huang H. Involvement of calcium-dependent protein kinase C in arsenite-induced genotoxicity in Chinese hamster ovary cells. J. Cell. Biochem. 64:1997;423-433.
109. Wang T.S., Shu Y.F., Liu Y.C., Jan K.Y., Huang H. Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology. 121:1997;229-237.
110. Lynn S., Shiung J.N., Gurr J.R., Jan K.Y. Arsenite stimulates poly (ADP-ribosylation) by generation of nitric oxide. Free Radic. Biol. Med. 24:1998;442-449.
111. Gurr J.R., Liu F., Lynn S., Jan K.Y. Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei. Mutat. Res. 416:1998;137-148.
112. Endo G., Kuroda K., Okamoto A., Horiguchi S. Dimethylarsenic acid induces tetraploids in Chinese hamster cells. Bull. Environ. Contam. Toxicol. 48:1992;131-137.
113. Ueda H., Kuroda K., Endo G. The inhibitory effect of selenium on induction of tetraploidy by dimethylarsinic acid in Chinese hamster cells. Anticancer Res. 17:1997;1939-1943.
114. Barrett J.C., Lamb P.W., Wang T.C., Lee T.C. Mechanisms of arsenic-induced cell transformation. Biol. Trace. Elem. Res. 21:1989;421-429.
115. Wiencke J.K., Yager J.W. Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane. Environ. Mol. Mutagen. 19:1992;195-200.
116. Jha A.N., Noditi M., Nilsson R., Natarajan A.T. Genotoxic effects of arsenite on human cells. Mutat. Res. 284:1992;215-221.
117. Vega L., Gonsebatt M.E., Ostrosky-Wegman P. Aneugenic effects of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. Mutat. Res. 334:1995;365-373.
118. Ramirez P., Eastmond D.A., Laclette J.P., Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res. 386:1997;291-298.
119. Zanzoni F., Jung E.G. Arsenic elevates the sister chromatid exchange (SCE) rate in human lymphocytes in vitro. Arc. Dermatol. Res. 267:1980;91-95.
120. Nordenson I., Sweins A., Beckman L. Chromosome aberrations in cultured human lymphocytes exposed to trivalent and pentavalent arsenic. Scand. J. Work. Environ. Health. 4:1981;277-281.
121. Crossen P.E. Arsenic and SCE in human lymphocytes. Mutat. Res. 119:1983;415-419.
122. Wen W.N., Lieu T.L., Chang H.J., Wuu S.W., Yau M.L., Jan K.Y. Baseline and sodium arsenite-induced sister chromatid exchanges in cultured lymphocytes from patients with Blackfoot disease and healthy persons. Hum. Genet. 59:1981;201-203.
123. Sahu R.K., Katsifis S.P., Kinney P.L., Christie N.T. Effects of nickel sulphate, lead sulphate and sodium arsenite alone with UV light on sister chromatid exchanges in cultured human lymphocytes. Mol. Toxicol. 2:1989;129-136.
124. Iwami K., Kuroda K., Endo G. Induction of mitotic arrest and aneuploidy by organic arsenic compounds in human lymphocytes. Appl. Organomet. Chem. 11:1997;743-749.
125. Rasmussen R.E., Menzel D.B. Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cells lines. Mutat. Res. 386:1997;299-306.
126. Kaise T., Ochi T., Oya-Ohta Y., Hanaoka K., Sukurai T., Saitoh T., Matsubara C. Cytotoxicological aspects of organic arsenic compounds contained in marine products using the mammalian cell culture technique. Appl. Organomet. Chem. 12:1998;137-143.
127. Happle R., Hoehn H. Cytogenetic studies on cultured fibroblast-like cells derived from basal cell carcinoma tissue. Clin. Genet. 4:1973;17-24.
128. Huang R.N., Ho I.C., Yih L.H., Lee T.C. Sodium arsenite induces chromosome endoreduplication and inhibits protein phosphatase activity in human fibroblasts. Environ. Mol. Mutagen. 25:1995;188-196.
129. Oya-Ohta Y., Kaise T., Ochi T. Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat. Res. 357:1996;123-129.
130. Yih L.H., Lee T.C. Effects of exposure protocols on induction of kinetochore-plus and minus micronuclei by arsenite in diploid human fibroblasts. Mutat. Res. 440:1999;75-82.
131. Nakamuro K., Sayato Y. Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat. Res. 88:1981;73-80.
132. Petres J., Schmid-Ulrich K., Wolf V. Chromosomenaberrationen an menschlichen Lymphozyten bei chronischen Arsenschaden. Deut. Med. Wschr. 2:1970;79-80.
133. Petres J., Baron D., Hagedorn M. Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies. Environ. Health Perspect. 19:1977;223-227.
134. Beckman G., Beckman L., Nordenson I. Chromosome aberrations in workers exposed to arsenic. Environ. Health. Perspect. 19:1977;145-146.
135. Nordenson I., Beckman G., Beckman L., Nordstrom S. Occupational and environmental risks in and around a smelter in northern Sweden. II. Chromosomal aberrations in workers exposed to arsenic. Hereditas. 88:1978;47-50.
136. Nordenson I., Salmonsson S., Brun E., Beckman G. Chromosome aberrations in psoriatic patients treated with arsenic. Hum. Genet. 48:1979;1-6.
137. Hu G.G. Investigation of protective effect of selenium on genetic material among workers exposed to arsenic. Chung Hua Yu Fang I Hsueh Tsa Chih. 23:1989;286-288.
138. Ostrosky-Wegman P., Gonsebatt M.E., Montero R., Vega L., Barba H., Espinosa J. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat. Res. 250:1991;477-482.
139. Gonsebatt M.E., Vega L., Salazar A.M., Montero R., Guzman P., Blas J., Del Razo L.M., Garcia-Vargas G., Albores A., Cebrian M.E., Kelsh M., Ostrosky-Wegman P. Cytogenetic effects in human exposure to arsenic. Mutat. Res. 386:1997;219-228.
140. Maki-Paakkanen J., Kurttio P., Paldy A., Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ. Mol. Mutagen. 32:1998;301-313.
141. Brown J.P., Fan A.M. Arsenic: risk assessment for California drinking water standards. J. Hazardous Mater. 39:1994;149-159.
142. Liou S.H., Lung J.C., Chen Y.H., Yang T., Hsieh L.L., Chen C.J., Wu T.N. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res. 59:1999;1481-1484.
143. Vig B.K., Figueror M.L., Cornforth M.N., Jenkins S.H. Chromosome studies in human subjects chronically exposed to arsenic in drinking water. Am. J. Ind. Med. 6:1984;325-338.
144. Burgdorf W., Kurvink K., Cervenka J. Elevated sister chromatid exchange rate in lymphocytes of subjects treated with arsenic. Hum. Genet. 36:1977;69-72.
145. Lerda D. Sister chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mutat. Res. 312:1994;111-120.
146. Hantson P., Verellen-Dumoulin C., Libouton J.M., Leonard A., Leonard E.D., Mahieu P. Sister chromatid exchanges in human peripheral blood lymphocytes after ingestion of high doses of arsenicals. Int. Arch. Occup. Environ. Health. 68:1996;342-344.
147. Hsu Y.H., Li S.Y., Chiou H.Y., Yeh P.M., Liou J.C., Hsueh Y.M., Chang S.H., Chen C.J. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. Mutat. Res. 386:1997;241-251.
148. Dulout F.N., Grillo C.A., Seoane A.I., Maderna C.R., Nilsson R., Vahter M., Darroudi F., Natarajan A.T. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat. Res. 370:1996;151-158.
149. Yager J.W., Wiencke J.K. Enhancement of chromosomal damage by arsenic: implications for mechanism. Environ. Health Perspect. 101:1993;79-82.
150. Nilsson R., Jha A.N., Zaprianov Z., Natarajan A.T. Chromosomal aberrations in humans exposed to arsenic in the Srednogorie area, Bulgaria. Fresenius Environ. Bull. 2:1993;59-64.
151. Warner M.L., Moore L.E., Smith M.T., Kalman D.A., Fanning E., Smith A.H. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic contaminated water in Neveda. Cancer Epidemiol. Biomarkers. Prev. 3:1994;583-590.
152. Moore L.E., Warner M.L., Smith A.H., Kalman D., Smith M.T. Use of fluorescent micronucleus assay to detect the genotoxic effects of radiation and exposure in exfoliated human epithelial cells. Environ. Mol. Mutagen. 27:1996;176-184.
153. Moore L.E., Smith A.H., Hopenhayn-Rich C., Biggs M.L., Kalman D.A., Smith M.T. Decrease in bladder cell micronucleus prevalence after intervention to lower the concentration of arsenic in drinking water. Cancer Epidemiol. Biomarkers Prev. 6:1997;1051-1056.
154. Biggs M.L., Kalman D.A., Moore L.E., Hopenhayn-Rich C., Smith M.T., Smith A.H. Relationship of urinary arsenic to intake estimates and a biomarker of effect, Bladder cell micronuclei. Mutat. Res. 386:1997;185-195.
155. Li J.H., Rossman T.G. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol.Trace Element Res. 21:1989;373-381.
156. Shibata A., Ohneseit P.F., Tsai Y.C., Spruch C.H., Nichols P.W., Chiang H.S., Lai M.K., Jones P.A. Mutational spectrum in the p53 gene in bladder tumour from the endemic areas of black foot disease in Taiwan. Carcinogenesis. 15:1994;1085-1087.
157. Snow E.T. Metal carcinogenesis: mechanistic implications. Pharmac. Ther. 53:1992;31-65.
158. Lee T.C., Tanaka N., Lamb P.W., Gilmer T.M., Barrett C.J. Induction of gene amplification by arsenic. Science. 241:1988;79-81.
159. Rossman T.G., Wolosin D. Differential susceptibility to carcinogen-induced amplification of SV40 and dhfr sequences in SV40-transformed human keratinocytes. Mol. Carcinogenesis. 6:1992;203-213.
160. Eguchi N., Kuroda K., Endo G. Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch. Environ. Contam. Toxicol. 32:1997;141-145.
161. King H., Lunford R.J. The relation between the constitution of arsenicals and their action on cell division. J. Chem. Soc. 8:1950;2086-2088.
162. Mass M.J. Human carcinogenesis by arsenic. Environ. Geochem. Health. 14:1992;49-54.
163. Beckman L., Nordenson I. Interaction between some common genotoxic agents. Human Hered. 36:1986;397-401.
164. Leonard A., Lauwerys R.R. Carcinogenicity, teratogenicity, and mutagenicity of arsenic. Mutat. Res. 75:1980;49-62.
165. Rudel R., Slayton T.M., Beck B.D. Implications of arsenic genotoxicity for dose response of carcinogenic effects. Regul. Toxicol. Pharmacol. 23:1996;87-105.
166. A. Basu, J. Mahata, P.K. Sarkar, J.N. Sarkar, A.K. Roy, G. Poddar, A. Nandi, P.K. Dutta, M. Das, A. Banerjee, S. Roychaudhury, K. Ray, A.T. Natarajan, R. Nilsson, A.K. Giri, Evaluation of the micronuclei formation in exfoliated epithelial cells of buccal mucosa, urinary bladder and in lymphocytes of the symptomatic individuals exposed to arsenic through drinking water in West Bengal, India, Mutat. Res. (2001) (communicated).
167. Brown C.C., Chu K.C. Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. J. Natl. Cancer Inst. 70:1983;455-463.
168. 3 induces NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RARα/PML proteins. Blood. 88:1996;1052-1061.
169. Z. Wang, T.G. Rossman, The carcinogenicity of arsenic, in: L.W. Chang, L. Magos, T. Suzuki (Eds.), Toxicology of Metals, Lewis Publishers, 1996, pp. 221-229.
170. M.I. Luster, J.L. Wilmer, D.R. Germolec, J. Spalding, et al., Role of keratinocyte-derived cytokines in chemical toxicity, Toxicol. Lett. 82/83 (1995) 281-296.
171. Vahter M., Couch R., Nermell B., Nilsson R. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmcol. 133:1995;262-268.
172. Wei M., Wanibuchi H., Yamamoto S., Li W., Fukushima S. Urinary bladder carcino-genicity of dimethylarsinic acid in male F344 rats. Carcinogenesis. 20:1999;1876-1876.
173. Chen Y., Megosha L.C., Gilmoura S.K., Sawickia J.A., O'Briena T.G. K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol. Lett. 116:2000;27-35.
174. Germolec D.R., Spalding J., Yu H.S., Chen G.S., Simeonovas P.P., Humble M.C., Bruccoleri A., Boorman G.A., Foley J.F., Yoshida T., Lusters M.I. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 153:1998;1775-1785.
175. Abernathy C.O., Liu Y.P., Longfellow D., Aposhian H.V., Beck B., Fowler B., Goyer R., Menzer R., Rossman T., Thompson C., Waalkes M. Arsenic: health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 107:1999;593-597.
176. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10907-10912.
177. Mass M.J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386:1997;263-277.
178. Little J.B. Failla memorial lecture: changing views of radiosensitivity. Radiat. Res. 140:1994;299-306.
179. Reznikoff C.A., Belair C., Savelieva E., Zhai Y., Pfeifer K., Yeager T., Thompson K.J., DeVeries S., Bindley C., Newton M.A. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human urepithlial cells. Genes Dev. 8:1994;2227-2240.
180. Hainaut P. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opinion. Oncol. 7:1995;76-82.
181. Maki C.G., Huibregtse J., Howley P.M. In vivo ubiquitination and proteosome-mediated degradation of p53. Cancer Res. 56:1996;2649-2654.
182. Klemperer N.S., Pickart C.M. Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway. J. Biol. Chem. 264:1989;19245-19252.
183. Rossman T.G., Wang Z. Expression cloning for arsenite-resistance resulted in isolation of tumour-suppressor fau cDNA: possible involvement of the ubiquitin system in arsenic carcinogenesis. Carcinogenesis. 20:1999;311-316.